BMC Cancer 2006, 6:130 http://www.biomedcentral.com/1471-2407/6/130 endothelial growth factor and its receptor. Cancer Sci 2006, 97:183-191. 11. Orengo AM, Spoletini L, Procopio A, Favoni RE, De Cupis A, Ardiz- zoni A, Castagneto B, Ribotta M, Betta PG, Ferrini S, Mutti L: Estab- lishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis. Eur Respir J 1999, 13:527-534. 12. Pass HI, Stevens EJ, Oie H, Tsokos MG, Abati AD, Fetsch PA, Mew DJ, Pogrebniak HW, Matthews WJ: Characteristics of nine newly derived mesothelioma cell lines. Ann Thorac Surg 1995, 59(4):835-844. 13. King JE, Thatcher N, Pickering CA, Hasleton PS: Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data. Histopathology 2006, 48:223-232. 14. Ordonez NG: Application of mesothelin immunostaining in tumor diagnosis. Am J Surg Pathol 2003, 27:1418-1428. 15. Nowak AK, Lake RA, Kindler HL, Robinson BWS: New approaches for mesothelioma: biologics, vaccines, gene therapy and other novel agents. Semin Oncol 2002, 29:82-96. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/6/130/pre pub Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime." Sir Paul Nurse, Cancer Research UK Your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours — you keep the copyright Submit your manuscript here: http://www.biomedcentral.com/info/publishing_adv.asp BioMedcentral Page 7 of 7 (page number not for citation purposes)